Mohs surgery more cost-effective for facial nonmelanoma skin cancers

June 1, 2004

Providence, R.I. - Mohs surgery appears to be a more cost-effective strategy for the treatment of facial nonmelanoma skin cancers (NMSCs) compared with traditional surgical excision, although the advantage of Mohs surgery is sensitive to the type of repair performed, according to the results of a study presented by Tracy L. Bialy, M.D., M.P.H., at the annual meeting of the Society for Investigative Dermatology